Search

Making cancer clinical trials SMMART

November 16, 2018

OHSU is giving cancer researchers new ability to test drug combinations aimed at overwhelming a tumors’ ability to adapt.

Scientists discover neurodegenerative disease in monkeys

July 27, 2018

OHSU discovery could accelerate development of new gene therapies for Batten disease.

OHSU, CDC unravel mysterious eye infection

February 12, 2018

Oregon woman infected with cattle eyeworm species--the first known case in humans.

Fresh approach to TB vaccine offers better protection

January 17, 2018

A unique platform that resulted in a promising HIV vaccine has also led to a new, highly effective vaccine against tuberculosis that is moving toward testing in humans.

Preserving memories to maintain cognitive health

November 22, 2017

A unique OHSU program strives to forestall memory loss through walking and reminiscing in north and northeast Portland.

Scientists discover genetic markers for severe form of multiple sclerosis

September 18, 2017

Scientists have uncovered two related cytokines and associated genetic markers that may explain why some people develop progressive multiple sclerosis, or MS.

Vaccine technology developed by OHSU scientists acquired by industry leaders

January 25, 2017

A first-of-its-kind vaccine technology platform developed by renowned scientists at OHSU in Portland, Oregon, has been acquired by Vir Biotechnology, a San Francisco-based biotech startup backed by leading industry investor ARCH Venture Partners and the Bill & Melinda Gates Foundation, a leading funder of global health initiatives.